Put your capabilities in front of the right development teams.
Accel Bio provides CDMO lead generation for contract development and manufacturing organizations. We connect manufacturing and development capabilities with relevant biopharma buyers through account research, phone outreach, qualification and meeting scheduling. Targeting focuses on modality, development stage and timelines, so your business development team can explore opportunities that fit your services.
Researcher · Sales development representative · Campaign manager
Campaign criteria to agree together. Each step adds context your sales team can use.
Selected results from our client presentation. Company names are withheld for confidentiality. These are individual campaign outcomes, not guarantees of future performance.
34 meetings in the first 6 months
Our campaign generated 34 meetings for a 900-person biologics CDMO in its first six months, with multiple deals reaching final vendor selection. These opportunities were not reported as closed contracts.
Meeting counts are reported as presented; they do not establish attendance or sales-qualified opportunities. Deal stages reflect the time of reporting.
An interested sponsor is not automatically a good manufacturing fit. Modality, scale, service scope and timing can rule an opportunity in or out before a technical discussion starts. A focused campaign gives your business development team that context instead of treating every biotech company as a potential project.
Accel Bio’s dedicated team brings together a researcher, sales development representative and campaign manager. The published service covers account research, phone-led outreach, qualification, scheduling and reporting on activity, conversations, objections and meetings.
Start with the capabilities you want to grow and the work your team can realistically support. Define target programs and the buyer roles involved in outsourcing, then use outreach to test the apparent fit. Public program milestones can inform research; they do not prove a sponsor is selecting a new partner.
Translate your commercial priorities into clear account criteria. Separate capabilities you want to promote from work you cannot support.
Map relevant development teams and contacts against your target profile, including modality, stage and service fit where information is available.
Use phone-led outreach to explore outsourcing needs, fit and the sponsor’s next step. Capture objections and timing signals as well as interest.
Schedule the conversation and share the context your business development team needs to decide whether a technical follow-up is worthwhile.
| Campaign focus | What to establish |
|---|---|
| Drug substance and process development | Match modality and development stage to process needs, scale and the CDMO’s actual capabilities. |
| Drug product and fill-finish | Qualify formulation or dosage requirements, development phase and anticipated supply needs. |
| Analytical services and transfer | Explore the analytical need, transfer context and timing for a technical conversation. |
| Manufacturing and technical operations buyers | Identify relevant CMC, technical operations, external manufacturing and sourcing stakeholders. |
Illustrative scenario, not a client case study or reported result.
Consider a CDMO targeting clinical-stage developers for sterile fill-finish work. A program announcement can identify an account to research, but the sponsor’s requirements still need to be understood before calling it a suitable opportunity.
A useful brief separates confirmed information from open questions: program context, requested service, timing, relevant contacts and next action. Detailed technical fit, quality assessment and commercial terms remain part of the sponsor’s evaluation with your CDMO.
A qualified CDMO lead fits the provider’s target profile and has a relevant development or manufacturing need. Modality, service scope, program stage, timing and stakeholder role help determine whether a technical discussion is appropriate.
Relevant roles can include CMC, technical operations, external manufacturing and sourcing leaders. The appropriate contacts depend on the sponsor’s size, program stage and how it selects outsourcing partners.
Yes. Accel Bio’s published approach maps manufacturing capabilities to modality, phase and timelines. A focused campaign can prioritize a defined service line, with detailed targeting criteria agreed before outreach.
No. Financing or a program milestone can justify further research, but it does not establish an outsourcing requirement or an open vendor selection. Qualification should test the need and timing through an actual conversation.
Track account coverage, meaningful conversations, held meetings and BD-accepted opportunities separately. Then follow proposal and contract outcomes in your sales process; a meeting count alone does not establish commercial value.
Scope depends on your capabilities, target market and outreach needs. Discuss pricing, launch milestones and responsibilities with Accel Bio. There is no universal timeline from first contact to a manufacturing agreement.
Accel Bio’s published lead generation offering covers North America and Europe. Agree the countries, language coverage and target accounts for your campaign during scoping.
Reach the people who can move your business forward.
Start sponsor conversations that fit the science you do.
Bring your target market, service priorities and current sales challenges. Let’s discuss where a dedicated outbound team could help.
Discuss your campaign Book a 30-minute conversation with Accel Bio.